Overview
Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy
Status:
Unknown status
Unknown status
Trial end date:
2014-12-01
2014-12-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
In second trimester abortion above 22 weeks the investigators usually inject intra-cardiac Kcl for feticide. Digoxin intra-amniotic injection has been described in the literature in doses of 1-1.5 mg. with a success rate of about 80%, and up to 24 weeks. Our aim in this study is to investigate the safety and success rate of 1.5-2 mg. digoxin, intra-amniotic up to 30 weeks pregnancy .Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Meir Medical CenterTreatments:
Digoxin
Criteria
Inclusion Criteria:- healthy women with no medical, cardiac, hypertension, liver or renal problems -
pregnant in their 20-30 week gestation,
- that need to have abortion due to fetal anomalies or any other reason
- need to have feticide prior to the procedure
Exclusion Criteria:
- any patient with medical problem that may be a contra-indication to Digoxin
- cardiac problems,
- prior cardiac surgery,
- liver or kidney disease,
- hyper tension etc.